Pulmonology

FDA approves new rescue inhaler for adults with asthma

The U.S. Food and Drug Administration has approved Airsupra (albuterol and budesonide) inhalation aerosol for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in patients with asthma 18 years of age and older, according to a press release. This is the first combination...